[1]
Mikael Bjursell, “Therapeutic CRISPR/Cas9 Genome Editing in a Humanized Mouse Model Ameliorates \(\alpha\)1-antitrypsin Deficiency Phenotype”, RPMAB-V9, pp. 14–31, Jan. 2025.